, , , , , ,

Baricitinib (Olumiant) Tablets | JAK Inhibitor for Rheumatoid Arthritis & Alopecia | Generic Medicine

Baricitinib (Olumiant) is an oral Janus Kinase (JAK) inhibitor prescribed for adults with moderate to severe rheumatoid arthritis, severe alopecia areata, and certain hospitalized COVID-19 patients under medical supervision. It works by reducing inflammatory signaling within the immune system.

Feature Details
Generic Baricitinib
Class JAK1/JAK2 Inhibitor
Strength 2 mg / 4 mg
Form Oral (60) Tablet
Uses Vitiligo (off-label), Eczema, Rheumatoid Arthritis, Alopecia areata
Generic Brand Barinib
Category JAK Inhibitor Medicine

What is Baricitinib (Olumiant)?

Baricitinib, marketed under the brand name Olumiant, is a selective Janus Kinase (JAK1/JAK2) inhibitor that helps reduce inflammation caused by autoimmune diseases. It is widely prescribed for rheumatoid arthritis and severe alopecia areata and may also be used in selected hospitalized COVID-19 patients according to approved clinical guidelines.

Baricitinib is taken orally once daily and is available in multiple strengths depending on the patient’s condition and physician recommendation.


  • Product Name: Baricitinib (Olumiant) Tablets
  • Brand: Olumiant
  • Generic Name: Baricitinib
  • Dosage Form: Tablet
  • Drug Class: JAK Inhibitor
  • Prescription Required: Yes
  • Availability: In Stock
  • Condition Treated: Rheumatoid Arthritis, Severe Alopecia Areata, Selected Hospitalized COVID-19 Patients

Indications

Baricitinib is indicated for:

  • Moderate to severe Rheumatoid Arthritis
  • Severe Alopecia Areata
  • Certain hospitalized COVID-19 patients
  • Other inflammatory autoimmune diseases (when prescribed)

Mechanism of Action

Baricitinib inhibits Janus Kinase (JAK1 and JAK2), blocking intracellular signaling pathways responsible for inflammation. This decreases immune system overactivity and reduces symptoms such as pain, swelling, and tissue damage.


Benefits

  • Helps reduce joint pain and inflammation
  • Improves physical function
  • Slows progression of rheumatoid arthritis
  • Promotes hair regrowth in severe alopecia areata
  • Oral once-daily treatment
  • No injections required
  • Clinically proven efficacy
  • Long-term disease management option

Available Strengths

  • Baricitinib 1 mg
  • Baricitinib 2 mg
  • Baricitinib 4 mg

Availability depends on manufacturer and country.


Dosage

The dosage should always be determined by a qualified healthcare professional.

Typical dosing:

  • Rheumatoid Arthritis: 2 mg once daily
  • Alopecia Areata: 2–4 mg once daily depending on severity
  • Dose adjustment may be necessary in patients with kidney impairment.

Possible Side Effects

Common side effects include:

  • Upper respiratory infections
  • Nausea
  • Headache
  • Acne
  • Elevated cholesterol
  • Cold sores (Herpes simplex)

Serious side effects may include:

  • Serious infections
  • Blood clots
  • Tuberculosis
  • Liver enzyme abnormalities
  • Low blood cell counts

Seek immediate medical attention if serious adverse reactions occur.


Precautions

Inform your healthcare provider if you have:

  • Active infections
  • Tuberculosis
  • Liver disease
  • Kidney disease
  • Blood clot history
  • Pregnancy or breastfeeding
  • Cancer history

Regular laboratory monitoring may be recommended.


Drug Interactions

Baricitinib may interact with:

  • Immunosuppressants
  • Biologic therapies
  • Live vaccines
  • Certain antiviral medications
  • Strong OAT3 inhibitors

Consult your physician before combining medications.


Storage

Store below 30°C.

Keep away from moisture, sunlight, and children.

Frequently Asked Questions (FAQ)

What is Baricitinib used for?

Baricitinib is used to treat moderate to severe rheumatoid arthritis, severe alopecia areata, and certain hospitalized COVID-19 patients under medical supervision.


Is Baricitinib the same as Olumiant?

Yes. Olumiant is the brand name of the generic medicine Baricitinib.


Is Baricitinib a steroid?

No. It is a Janus Kinase (JAK) inhibitor and is not a corticosteroid.


How long does Baricitinib take to work?

Some patients notice improvement within several weeks, while full therapeutic benefit may take several months depending on the condition being treated.


Can Baricitinib cause infections?

Yes. Because it affects the immune system, Baricitinib may increase the risk of infections. Patients should be monitored by their healthcare provider.


Can Baricitinib help hair regrowth?

Yes. Baricitinib is approved in several countries for severe alopecia areata and has shown significant hair regrowth in eligible patients.


Is Baricitinib chemotherapy?

No. It is a targeted immunomodulatory medicine and not a chemotherapy drug.


Do I need a prescription?

Yes. Baricitinib should only be used under the supervision of a qualified healthcare provider.

Product Categories

  • Rheumatology Medicines
  • Autoimmune Disease Treatment
  • JAK Inhibitors
  • Specialty Medicines
  • Prescription Medicines
Let's chat